Citations

Clear

9383 citation(s) found for "Thomas, PS".

Six‐per‐second spike‐and‐wave pattern in the electroencephalogram
Thomas, Juergen E., Klass, Donald W.

Mayo Clinic

Neurology | May 13, 2012 | Volume: 18 | Issue: 6 | Pages: 587-593

10.1212/wnl.18.6.587 | PMID 5691019 Get It

Orthostatic hypotension as the presenting sign in craniopharyngioma
Thomas, Juergen E., Schirger, A, Love, J. Grafton , Hoffman, David L.

Mayo Clinic

Neurology | May 13, 2012 | Volume: 11 | Issue: 5 | Pages: 418-418

10.1212/wnl.11.5.418 | PMID 13776491 Get It

Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1
Gutmann, David H. , James, C. David , Pöyhönen, Minna , Louis, David N. , Ferner, Rosalie E. , Guha, A. , Hariharan, S., Viskochil, David , Perry, Arie

Mayo Clinic

Neurology | May 13, 2012 | Volume: 61 | Issue: 10 | Pages: 1397-1400

10.1212/wnl.61.10.1397 | PMID 14638962 Get It

Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer‐related syndromes
Vernino, Steven , Adamski, Jill , Kryzer, Thomas J., Fealey, Robert D., Lennon, Vanda A. , Vernino, Steven

Mayo Clinic

Neurology | May 13, 2012 | Volume: 50 | Issue: 6 | Pages: 1806-1813

10.1212/wnl.50.6.1806 | PMID 9633732 Get It

Differential diagnosis between radiation and tumor plexopathy of the pelvis
Thomas, Juergen E., Cascino, Terrence L., Earle, John D.

Mayo Clinic

Neurology | May 13, 2012 | Volume: 35 | Issue: 1 | Pages: 1-1

10.1212/wnl.35.1.1 | PMID 2981416 Get It

Segmental zoster paresis—a disease profile
Thomas, Juergen E., Howard, F

Mayo Clinic

Neurology | May 13, 2012 | Volume: 22 | Issue: 5 | Pages: 459-459

10.1212/wnl.22.5.459 | PMID 4673442 Get It

Histopathologic Overlap between Fibrosing Mediastinitis and IgG4-Related Disease
Peikert, Tobias, Shrestha, Bijayee, Aubry, Marie Christine, Colby, Thomas V. , Ryu, Jay H. , Sekiguchi, Hiroshi , Smyrk, Thomas C. , Yi, Eunhee S. , Specks, Ulrich , Ryu, Jay H

Mayo Clinic

International Journal of Rheumatology | May 10, 2012 | Volume: 2012 | Issue: No issue available | Pages: 1-7

10.1155/2012/207056 | PMID 22654916 Get It

Fibrosing mediastinitis (FM) and IgG4-related disease (IgG4-RD) are two fibroinflammatory disorders with potentially overlapping clinical and radiological features. In this paper, we looked for histopathologic features of IgG4-RD and enumerated infiltrating IgG4-positive plasma cells within mediastinal tissue biopsies from FM patients. We identified 15 consecutive FM surgical mediastinal tissue biopsies between 1985 and 2006. All patients satisfied the clinical and radiological diagnostic criteria for FM. All patients had either serological or radiological evidence of prior histoplasmosis or granulomatous disease, respectively. Formalin-fixed paraffin-embedded tissue sections of all patients were stained for H&E, IgG, and IgG4. Three samples met the predefined diagnostic criteria for IgG4-RD. In addition, characteristic histopathologic changes of IgG4-RD in the absence of diagnostic numbers of tissue infiltrating IgG4-positive plasma cells were seen in a number of additional cases (storiform cell-rich fibrosis in 11 cases, lymphoplasmacytic infiltrate in 7 cases, and obliterative phlebitis/arteritis in 2 cases). We conclude that up to one-third of histoplasmosis or granulomatous-disease-associated FM cases demonstrate histopathological features of IgG4-RD spectrum. Whether these changes occur as the host immune response against Histoplasma or represent a manifestation of IgG4-RD remains to be determined. Studies to prospectively identify these cases and evaluate their therapeutic responses to glucocorticoids and/or other immunosuppressive agents such as rituximab are warranted.
Abstract B39: Mammographic density and breast lobular involution
Ghosh, Karthik, Wang, Alice , Visscher, Daniel W., Reynolds, Carol, Brandt, Kathleen R. , Sellers, Thomas A. , Hartmann, Lynn C. , Vachon, Celine M. , Scott, Christopher G. , Pankratz, V. Shane , Vachon, Celine M.

Mayo Clinic

Cancer Prevention Research | May 2, 2012 | Volume: 1 | Issue: 7_Supplement | Pages: B39-B39

10.1158/1940-6207.prev-08-b39 Get It

Abstract B39 Background The breast glandular epithelium is composed of lobules that undergo age-related involution that increases as women age and has been associated with lowered breast cancer risk. Mammographic density (MD) is an established risk factor for breast cancer that has been shown to decrease with age. This study examined the association of age-related lobular involution with mammographic breast density. Materials and Methods The study sample was selected from approximately 20,000 healthy women who were enrolled in a screening cohort at the Mayo Clinic (Mayo Mammography Health Study) from 2003 to 2006 and had a benign breast biopsy (BBD) within 2 years of the enrollment mammogram. A quantitative measure of mammographic density, percent density (PD) was estimated on the enrollment mammogram, in addition to its components dense and nondense area (NDA). All biopsies were reviewed by a breast pathologist for the type of benign breast disease (BBD) as well as lobular involution status. Involution was defined as the proportion of terminal ductal lobular units (TDLUs) in the background tissue on biopsy that showed at least 50% decrease in size and number of acini from normal lobules and was subjectively assessed as: No- 0% involution, Partial- 1 to 74%, or Complete- >75% involution. Mean density was estimated for the 3 categories of involution using generalized linear models and square root transformation. Confounders were assessed including age, parity, body mass index (BMI), type of BBD, menopausal status, age at first birth and family history Results A total of 317 women from the MMHS had BBD within 2 years of enrollment. Mean age at BBD diagnosis in this sample was 55 years. Age- and BMI- adjusted analyses suggested an inverse association of involution and percent density with adjusted mean PD values of 23.3 (95%CI [17.2, 30.3]) for no involution, 21.9 (95%CI [20.0, 23.9]) for partial involution, and 17.8 (95% CI [14.7, 21.3]) for complete involution (p for trend 0.05). This trend was driven primarily by the positive association of involution with nondense area with adjusted mean NDA values of 103.1cm2 (95% CI [86.1, 121.7]) for no involution, 104.9 cm2 (95% CI [99.4, 110.7]) for partial involution, and 126.2 cm2 (95% CI [115.0, 137.9]) for complete involution (p for trend 0.004). Discussion Our findings suggest that MD is inversely associated with involution of breast tissues, providing a plausible mechanism through which MD influences breast cancer risk. Citation Information: Cancer Prev Res 2008;1(7 Suppl):B39.
Abstract A115: Alcohol use and molecularly defined colorectal cancer risks in a prospective study of older women
Razzak, Anthony, Tillmans, Lori S. , Wang, Alice H., Weisenberger, Daniel J. , Lynch, Charles F. , Anderson, Kristin E. , Smyrk, Thomas C. , Thibodeau, Stephen N. , Oxentenko, Amy S. , Vierkant, Robert A. , Laird, Peter W. , Haile, Robert W. , Harnack, Lisa , Potter, John D. , Slager, Susan L. , Cerhan, James R. , Limburg, Paul J.

Mayo Clinic

Cancer Prevention Research | May 2, 2012 | Volume: 3 | Issue: 1_Supplement | Pages: A115-A115

10.1158/1940-6207.prev-09-a115 Get It

Abstract Background: Colorectal cancer (CRC) is the third most common incident cancer among women in the United States. Alcohol use has been proposed as a CRC risk factor, but existing observational data remain inconsistent. To date, relatively few studies have examined associations between alcohol use and CRC risk based on molecularly-defined subtypes. Aim: To evaluate associations between alcohol use and incident CRC overall, as well as by molecularly-defined subtypes including microsatellite instability (MSI), CpG island methylator phenotype (CIMP) and BRAF mutation status in the prospective, population-based, Iowa Women's Health Study (IWHS). Methods: The IWHS recruited 41,836 randomly selected Iowa women, ages 55–69 years at enrollment, in 1986. Women with prevalent cancers or no follow-up were excluded, leaving 38,001 eligible for this study. Alcohol use was obtained from a self-administered food frequency questionnaire at study baseline. Incident CRCs were identified through annual linkage with the State Health Registry of Iowa. Archived, paraffin-embedded tissue specimens were recently requested for incident CRC cases diagnosed through December 31, 2002. In the present study, useable tissue specimens were obtained and molecularly characterized for 563/1,255 cases (45%), whose baseline age, body mass index, physical activity level, total energy intake and alcohol use were similar to non-retrieved cases (p > 0.05 for each comparison). Alcohol use was categorized as never (n=21,464), < 3.4 g/day (n=8,313) and > 3.4 g/day (n=8,224), based on the median split among users. Molecularly-defined CRC subtypes were categorized as MSI-high (MSIH; n=148), MSI-low or microsatellite stable (MSI-L/MSS; n=400); CIMP-positive (n=167) or CIMP-negative (n=368); and BRAF-mutation (n=154) or BRAF-wildtype (n=391). Relative risks (RRs) and 95% confidence intervals (95% CIs) were estimated for alcohol use compared to never drinkers, using multivariable Cox regression models adjusted for body mass index, waist-to-hip ratio, smoking status, physical activity level, exogenous estrogen use, and daily intakes of total energy, total fat, red meat, sucrose, calcium, folate, methionine and vitamin E. Results: There was no statistically significant association between alcohol use and overall CRC risk (RR=1.00; 95% CI = 0.86–1.15 for < 3.4 g/day versus none; RR=1.06; 95% CI=0.91–1.24 for >3.4 g/day versus none). Further, there were no associations with alcohol use for specific, molecularly-defined CRC subtypes (RRs shown for > 3.4 g/day versus none): MSI-H (RR=1.07; 95% CI=0.70–1.64); MSI-L or MSS (RR=1.12; 95% CI=0.85–1.47); CIMP-positive (RR=0.97; 95% CI=0.64–1.47); CIMP-negative (RR=1.13; 95% CI=0.85–1.50); BRAF-mutation (RR=0.94; 95% CI=0.61–1.45); and BRAF-wildtype (RR=1.20; 95% CI=0.91–1.57). Conclusion: In this cohort of older women, alcohol use did not appear to be a risk factor for incident CRC, overall or by the defined molecular subtypes. Citation Information: Cancer Prev Res 2010;3(1 Suppl):A115.
Genotype patterns atPICALM, CR1, BIN1, CLU, andAPOEgenes are associated with episodic memory
Barral, Sandra , Bird, Thomas D., Goate, Alison , Farlow, MR, Diaz‐Arrastia, Ramon , Bennett, David A. , Graff-Radford, N. R., Stern, Yaakov , Ott, Jürg , Mayeux, Richard , Kowall, Neil W. , Williamson, Jennifer, Santana, Vincent, Schmechel, Donald E., Gaskel, Peter, Farlow, Martin R. , Faber, Kelley, Horner, Kelly, Growdon, John H., Blacker, Deborah , Tanzi, Rudolph E. , Kuntz, Karen M. , Norgaard, Lindsay, Larson, Nathan, Kistler, Dana, Parfitt, Francine, Haddow, Jenny, Silverman, Jeremy M. , Beeri, Michal Schnaider , Sano, Mary , Wang, Joy , Lally, Rachel, Johnson, Nancy, Mesulam, Marcel, Weıntraub, Sandra , Bigio, Eileen H. , Kaye, Jeffery, Kramer, Patricia, Payne-Murphy, Jessica, Jacobs, Holli, Chang, Joon, Arends, Danielle, Harrell, Lindy, Bartzokis, George, Cummings, Jeffery L., Lu, Po H. , Toland, Usha, Smith, Charles , Brickhouse, Alise, Trojanowski, John Q. , DeKosky, Steven T. , Weamer, Elise A., Chui, Helena C., Varpetian, Arousiak, Rosenberg, Roger N., Schellenberg, Gerard D. , Raskind, Murray A. , Rumbaugh, Malia, Nickel, Kate, Norton, Joanne, Levitch, Denise, Grant, B., Coats, Mary A., Levey, Allen, Rosen, Ami, Anosike, Ezinna, Bennett, David A. , Wilson, Robert S. , Boeve, Bradley F. , Sweet, Robert A. , Wilson, R. J. , Foroud, Tatiana , Green, Robert C. , Farrer, Lindsay A. , Ghetti, Bernardino , Prentice, Heather A. , Hyman, Bradley T. , Larson, Nathan, Kaye, Jeffery, Deerlin, Vivianna M. Van , Wood, Elisabeth McCarty , Davis, Barbara Allen , Morris, John A. , Stern, Yaakov , Goate, Alison M , Diaz-Arrastia, Ramon

Mayo Clinic

Neurology | April 27, 2012 | Volume: 78 | Issue: 19 | Pages: 1464-1471

10.1212/wnl.0b013e3182553c48 | PMID 22539578 Get It